Department profile
Morrison Foerster

Life Sciences

Asia-Pacific Guide 2026 : Asia-Pacific Region


Morrison Foerster

Chambers Review

Provided by Chambers

Life Sciences - Asia-Pacific Region

Band 2

Band 2


What the Team is Known For
Thanks to its global network, Morrison Foerster is well placed to provide IP and corporate support to biotech companies and leading investors on joint ventures, funding, patent litigation and enforcement, and licensing issues in the life sciences sphere. It is also noted for core technology expertise within the sector and an impressive transactional capability across the Asia-Pacific region. The firm is particularly well versed in negotiating the licensing and development of pharmaceutical products as part of joint venture arrangements. The team regularly coordinates venture capital and corporate transactions with a network of colleagues based in offices across the USA.
Notable practitioners

Gordon Milner in Hong Kong and Sun Chuan in Shanghai, are key contacts for the China life sciences practice. The key contacts for the firm's life sciences practice in Japan are Masato Hayakawa and Yukihiro Terazawa.

Work Highlights

Provided by Chambers

  • Morrison Foerster advised Ono Pharmaceuticals on its negotiations with IONIS Pharmaceuticals on a licence agreement to exclusively develop, manufacture and commercialise pharmaceutical products containing IONIS’ proprietary ASO compound.

Strengths

Provided by Chambers

  • The firm’s strengths from our view is that they have a culture where the advisers are top class but socially are collaborative, responsive, flexible, efficient and pragmatic.

    Life Sciences respondentAsia-Pacific
  • The team fully understands our preferences and is good at quickly and accurately grasping complex contents.

    Life Sciences respondentAsia-Pacific

Morrison Foerster has rankings in the following guides

What success is built on

Chambers is the leading data and intelligence partner for the legal sector.

Explore thought leadership